Abstract
Peripheral vascular disease is a serious and common complication in patients with diabetes mellitus (DM). Evaluation is, conventionally, by transcutaneous oxygen tension measurements (TcpO2), although this technique has some limitations in the evaluation of tissue viability. We have evaluated a new, radiolabelled, in vivo marker of tissue hypoxia, iodoazomycinarabino-side (IAZA), by comparing TcpO2 measurements with patterns of iodine-123 IAZA uptake in ten patients (19 lower limbs) with DM and peripheral vascular disease using conventional gamma camera imaging techniques. Normal uptake patterns were seen in limbs in which normal TcpO2 measurements were obtained. Diffusely increased uptake of [123I]IAZA was seen in limbs with reduced TcpO2 Focally increased uptake was seen in ulcers or in areas of atrophic skin change. A semiquantitative measure showed an inverse correlation between [123I]IAZA and TcpO2 values. These data suggest that tissue hypoxia can be imaged in this population of patients and that severity of disease can be assessed. A longitudinal prospective trial is now being developed.
This is a preview of subscription content, log in via an institution to check access.
References
Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers.Diabetes 1991; 40: 1305–1313.
Rooke TW, Osmundson PJ. The influences of age, sex, smoking, and diabetes on lower limb transcutaneous oxygen tension in patients with arterial occlusive disease.Arch Intern Med 1990; 150: 129–132.
Takagi-Smith M, Byrne P, Ameli FM, Provan JL, Jones DP. The measurement of transcutaneous oxygen tension (PTcO2) and its application in the vascular laboratory.Bruit 1984; 8: 213–216.
Hauser CJ, Klein SR, Mehringer CM, Appel P, Shoemaker WC. Assessment of perfusion in the diabetic foot by regional transcutaneous oximetry.Diabetes 1984; 33: 527–531.
Chapman JD, Baer K, Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.Cancer Res 1983; 43: 1523–1528.
Mannan RH, Somayaji VV, Lee J, Mercer JR, Chapman JD, Wiebe LI. Radioiodinated 1-(5-iodo-5-deoxy-β-D-arabino-furanosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.J Nucl Med 1991; 32: 1764–1770.
Parliament MB, Chapman JD, Urtasun RC, McEwan AJ, Golberg L, Mercer JR, Mannan RH, Wiebe LI. Non-invasive assessment of human tumour hypoxia with123I-iodoazomycin arabinoside: preliminary report of a clinical study.Br J Cancer 1992; 65: 90–95.
Groshar D, McEwan AJB, Parliament MB, Urtasun RC, Golberg LE, Hoskinson M, Mercer JR, Mannan RH, Wiebe LI, Chapman JD. Imaging tumor hypoxia and tumor perfusion.J Nucl Med 1993; 34: 885–888.
Hoffman JM, Rasey JS, Spence AM, Shaw DW, Krohn KA. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.Stroke 1987; 18: 168–176.
Martin GV, Caldwell JH, Rasey JS, Grunbaum Z, Cerqueira M, Krohn KA. Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.J Nucl Med 1989; 30: 194–201.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Arafaj, A., Ryan, E.A., Hutchison, K. et al. An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus. Eur J Nucl Med 21, 1338–1342 (1994). https://doi.org/10.1007/BF02426699
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02426699